Publikationen von Mathias V. Schmidt

Buffa, V.; Knaup, F. H.; Heymann, T.; Springer, M.; Schmidt, M. V.; Hausch, F.: Analysis of the Selective Antagonist SAFit2 as a Chemical Probe for the FK506-Binding Protein 51. ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

Yang, H.; Narayan, S.; Schmidt, M. V.: From ligands to behavioral outcomes: understanding the role of mineralocorticoid receptors in brain function. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS 26 (1), 2204366 (2023)

von Mucke-Heim, I.-A.; Urbina-Trevino, L.; Bordes, J.; Ries, C.; Schmidt, M. V.; Deussing, J. M.: Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and mice. MOLECULAR PSYCHIATRY (2022)

Manchia, M.; Gathier, A. W.; Yapici-Eser, H.; Schmidt, M. V.; de Quervain, D.; van Amelsvoort, T.; Bisson I, J.; Cryan, J. F.; Howes, O. D.; Pinto, L. et al.; Van der Wee, N. J.; Domschke, K.; Branchi, I.; Vinkers, C. H.: The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves. EUROPEAN NEUROPSYCHOPHARMACOLOGY 55, S. 22 - 83 (2022)

Häusl, A. S.; Balsevich, G.; Gassen, N. C.; Schmidt, M. V.: Focus on FKBP51: A molecular link between stress and metabolic disorders. MOLECULAR METABOLISM 29, S. 170 - 181 (2019)

Schmidt, M. V.: Linking neuropsychiatric disease to neuronal metabolism. NATURE METABOLISM (2023)

Schmidt, M. V.: The tricky business of predicting the future: How brain and body adapt to early life adversity. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 155, 105466 (2023)

Bajaj, T.; Haeusl, A. S.; Schmidt, M. V.; Gassen, N. C.: FKBP5/FKBP51 on weight watch: central FKBP5 links regulatory WIPI protein networks to autophagy and metabolic control. AUTOPHAGY (2022)

Schmidt, M. V.: Behavioral neuroscience for the next decade: Progress in complex behavioral analysis. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS 140, 104781 (2022)